Mapping the Binding of GluN2B-Selective N-Methyl-D-aspartate Receptor Negative Allosteric Modulators

被引:40
作者
Burger, Pieter B. [1 ]
Yuan, Hongjie [2 ]
Karakas, Erkan [3 ]
Geballe, Matthew [1 ]
Furukawa, Hiro [3 ]
Liotta, Dennis C. [1 ]
Snyder, James P. [1 ]
Traynelis, Stephen F. [2 ]
机构
[1] Emory Univ, Dept Chem, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Pharmacol, Atlanta, GA USA
[3] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
基金
美国国家卫生研究院;
关键词
AMINO-TERMINAL DOMAIN; ANTI-ISCHEMIC AGENTS; NMDA RECEPTOR; NR2B SUBUNIT; ANTAGONIST PROPERTIES; PI INTERACTIONS; IFENPRODIL; PROTEIN; SUBTYPE; MECHANISMS;
D O I
10.1124/mol.112.078568
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have used recent structural advances in our understanding of the N-methyl-D-aspartate (NMDA) receptor amino terminal domain to explore the binding mode of multiple diaryl GluN2B-selective negative allosteric modulators at the interface between the GluN1 and GluN2B amino-terminal domains. We found that interaction of the A ring within the binding pocket seems largely invariant for a variety of structurally distinct ligands. In addition, a range of structurally diverse linkers between the two aryl rings can be accommodated by the binding site, providing a potential opportunity to tune interactions with the ligand binding pocket via changes in hydrogen bond donors, acceptors, as well as stereochemistry. The most diversity in atomic interactions between protein and ligand occur in the B ring, with functional groups that contain electron donors and acceptors providing additional atomic contacts within the pocket. A cluster of residues distant to the binding site also control ligand potency, the degree of inhibition, and show ligand-induced increases in motion during molecular dynamics simulations. Mutations at some of these residues seem to distinguish between structurally distinct ligands and raise the possibility that GluN2B-selective ligands can be divided into multiple classes. These results should help facilitate the development of well tolerated GluN2B subunit-selective antagonists.
引用
收藏
页码:344 / 359
页数:16
相关论文
共 62 条
[1]   DIFFERENTIAL EXPRESSION OF 5 N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT MESSENGER-RNAS IN THE CEREBELLUM OF DEVELOPING-RATS AND ADULT-RATS [J].
AKAZAWA, C ;
SHIGEMOTO, R ;
BESSHO, Y ;
NAKANISHI, S ;
MIZUNO, N .
JOURNAL OF COMPARATIVE NEUROLOGY, 1994, 347 (01) :150-160
[2]   Halogen bonds in biological molecules [J].
Auffinger, P ;
Hays, FA ;
Westhof, E ;
Ho, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (48) :16789-16794
[3]   Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes [J].
Avenet, P ;
Leonardon, J ;
Besnard, F ;
Graham, D ;
Frost, J ;
Depoortere, H ;
Langer, SZ ;
Scatton, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 296 (02) :209-213
[4]   Oxamides as novel NR2B selective NMDA receptor antagonists [J].
Barta-Szalai, G ;
Borza, I ;
Bozó, É ;
Kiss, C ;
Agai, B ;
Proszenyák, A ;
Keserü, GM ;
Gere, A ;
Kolok, S ;
Galgóczy, K ;
Horváth, C ;
Farkas, S ;
Domány, G .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) :3953-3956
[5]   The midpoint method for parallelization of particle simulations [J].
Bowers, Kevin J. ;
Dror, Ron O. ;
Shaw, David E. .
JOURNAL OF CHEMICAL PHYSICS, 2006, 124 (18)
[6]   (3R,4S)-3-[4-(4-fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol:: A conformationally restricted analogue of the NR2B subtype-selective NMDA antagonist (1S,2S)-1-(4-hydroxyphenyl)-2(4-hydroxy-4-phenylpiperidino)-1-propanol [J].
Butler, TW ;
Blake, JF ;
Bordner, J ;
Butler, P ;
Chenard, BL ;
Collins, MA ;
DeCosta, D ;
Ducat, MJ ;
Eisenhard, ME ;
Menniti, FS ;
Pagnozzi, MJ ;
Sands, SB ;
Segelstein, BE ;
Volberg, W ;
White, WF ;
Zhao, DY .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (07) :1172-1184
[7]  
CARTER C, 1988, J PHARMACOL EXP THER, V247, P1222
[8]   (1S,2S)-1-(4-HYDROXYPHENYL)-2-(4-HYDROXY-4-PHENYLPIPERIDINO)-1-PROPANOL - A POTENT NEW NEUROPROTECTANT WHICH BLOCKS N-METHYL-D-ASPARTATE RESPONSES [J].
CHENARD, BL ;
BORDNER, J ;
BUTLER, TW ;
CHAMBERS, LK ;
COLLINS, MA ;
DECOSTA, DL ;
DUCAT, MF ;
DUMONT, ML ;
FOX, CB ;
MENA, EE ;
MENNITI, FS ;
NIELSEN, J ;
PAGNOZZI, MJ ;
RICHTER, KEG ;
RONAU, RT ;
SHALABY, IA ;
STEMPLE, JZ ;
WHITE, WF .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (16) :3138-3145
[9]  
Chenard BL, 1999, CURR PHARM DESIGN, V5, P381
[10]   SEPARATION OF ALPHA-1 ADRENERGIC AND N-METHYL-D-ASPARTATE ANTAGONIST ACTIVITY IN A SERIES OF IFENPRODIL COMPOUNDS [J].
CHENARD, BL ;
SHALABY, IA ;
KOE, BK ;
RONAU, RT ;
BUTLER, TW ;
PROCHNIAK, MA ;
SCHMIDT, AW ;
FOX, CB .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (10) :3085-3090